Meetings & Events

Master Clinician: CKD and Diabetes: Management of Diabetes in Patients with Progressive CKD

June 17, 2021

Session Date and Time:

Saturday, September 11
11:00–11:45 AM EDT

Learning Objectives:

  1. Discuss the renoprotection of new antihyperglycemic agents.
  2. Describe safe use of antihyperglycemic medications in patients with kidney disease.
  3. Identify clinical trials demonstrating that specific antihyperglycemic drugs delay the progression of kidney disease.

Return to the full CEU 2021 program.

Register Now

Faculty Information

Silvio E. Inzucchi, MDDr. Inzucchi is a Professor of Medicine at the Yale School of Medicine in New Haven, Conn., where he serves as Clinical Chief of the Section of Endocrinology and Medical Director of the Yale Diabetes Center.

He is well known as an author and lecturer in diabetes management for more than two decades. He served as co-chair of the ADA-EASD Position Statement on the Management of Hyperglycemia in Type 2 Diabetes and has held leadership roles in several large clinical trials related to diabetes medications and their cardiovascular impact.

Robert C. Stanton, MDDr. Stanton is Chief of the Kidney and Hypertension Section at the Joslin Diabetes Center, a Principal Investigator (Section on Vascular Cell Biology), and an Associate Professor of Medicine at Harvard Medical School. Dr. Stanton has given many invited lectures throughout the world and written many original articles and reviews on clinical and basic science aspects of diabetic kidney disease.

Dr. Stanton’s research is focused on the essential enzyme, glucose 6-phosphate dehydrogenase (G6PD). His lab has discovered that this enzyme (and associated pathway) is essential for cell survival and dysregulation of G6PD plays an important role in the pathogenesis of many diseases. He has received honorary professorships from other universities and a major lifetime-achievement teaching award for Sustained Excellence in Teaching from Harvard Medical School.

Rita R. Kalyani, MD, MHSDr. Kalyani is an Associate Professor of Medicine in the Division of Endocrinology, Diabetes & Metabolism at Johns Hopkins University School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins.

Dr. Kalyani is an active clinician and sees patients regularly in the Johns Hopkins Comprehensive Diabetes Center. She directs the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program.

A recipient of NIH grant funding, Dr. Kalyani's research focuses on diabetes and aging and investigates accelerated muscle loss, disability, and frailty in older adults with diabetes. Other research interests include sex differences in diabetes and heart disease and physical functioning in other endocrine and metabolic diseases. She has served on the editorial boards of several diabetes research journals and has authored more than 125 peer-reviewed publications.


Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.